November 21, 2023 - The ePROVIDE platform deploys new features and improves the display of key information.
Constantly evolving, our ePROVIDETM platform is frequently updated with comprehensive information, as well as optimized for the best user experience.
Discover the new functionalities and improvements:
Share your ePROVIDETM requests with colleagues
You can now work collaboratively with your team by simply sharing a link to your ePROVIDETM request. They will be able to visualize the content of the request, write messages, upload and download documents, and fulfill or edit work orders.
Identify COAs listed in the FDA and/or EMA qualification programs
In PROQOLID™, you can now identify COAs that are part of the EMA and/or FDA Qualification Programs by selecting one of the following filters: COA with EMA letter of support; COA with EMA opinion; COA FDA qualified; and COA accepted in the FDA qualification program.
About the EMA Qualification of novel methodologies for medicine development:
“The EMA offers scientific advice to support the qualification of innovative development methods for a specific intended use in the context of research and development into pharmaceuticals. This qualification process leads to a qualification opinion or qualification advice with letter of support.”
About the FDA COA qualification program:
“COA qualification is a regulatory conclusion that the COA is a well-defined and reliable assessment of a specified concept of interest for use in adequate and well-controlled studies in a specified context of use.”
Retrieve key information more easily
To facilitate your search and optimize your experience, the search engine has been enhanced:
- UX Optimization of the search results display for the PROQOLID™ catalog, PROLABELS™ and PROINSIGHT™
- Inclusion of the COA name in the endpoint description of PROLABELS™
- Addition of the Guidances’ date of publication and date of update in PROINSIGHT™
Discover these new functionalities and other improvements now.Visit ePROVIDE